These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 29085358)
1. Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer. Martin D; Rödel F; Winkelmann R; Balermpas P; Rödel C; Fokas E Front Immunol; 2017; 8():1225. PubMed ID: 29085358 [TBL] [Abstract][Full Text] [Related]
2. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ Front Immunol; 2018; 9():2354. PubMed ID: 30369930 [TBL] [Abstract][Full Text] [Related]
3. C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy. Martin D; Rödel F; Balermpas P; Winkelmann R; Fokas E; Rödel C Front Oncol; 2019; 9():1200. PubMed ID: 31788452 [No Abstract] [Full Text] [Related]
4. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy. Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012 [TBL] [Abstract][Full Text] [Related]
5. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy. Martin D; Rödel F; Balermpas P; Rödel C; Fokas E Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):221-230. PubMed ID: 28501560 [TBL] [Abstract][Full Text] [Related]
6. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy. Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872 [TBL] [Abstract][Full Text] [Related]
7. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma. Hu WH; Miyai K; Cajas-Monson LC; Luo L; Liu L; Ramamoorthy SL J Surg Oncol; 2015 Sep; 112(4):421-6. PubMed ID: 26287957 [TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus load and PD-1/PD-L1, CD8 Balermpas P; Martin D; Wieland U; Rave-Fränk M; Strebhardt K; Rödel C; Fokas E; Rödel F Oncoimmunology; 2017; 6(3):e1288331. PubMed ID: 28405521 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study. Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640 [TBL] [Abstract][Full Text] [Related]
11. Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy. Wakeham K; Murray L; Muirhead R; Hawkins MA; Sebag-Montefiore D; Brown S; Murphy L; Thomas G; Bell S; Whibley M; Morgan C; Sleigh K; Gilbert DC Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):638-649. PubMed ID: 34024700 [TBL] [Abstract][Full Text] [Related]
12. Preoperative leukocytosis is associated with increased tumor-infiltrating neutrophil extracellular traps and worse outcomes in esophageal cancer. Zhang H; Lv H; Weng M; Wang H; Cata JP; Chen W; Miao C Ann Transl Med; 2020 Apr; 8(7):441. PubMed ID: 32395485 [TBL] [Abstract][Full Text] [Related]
13. Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer. Wouters MC; Komdeur FL; Workel HH; Klip HG; Plat A; Kooi NM; Wisman GB; Mourits MJ; Arts HJ; Oonk MH; Yigit R; de Jong S; Melief CJ; Hollema H; Duiker EW; Daemen T; de Bruyn M; Nijman HW Clin Cancer Res; 2016 Feb; 22(3):714-24. PubMed ID: 26384738 [TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z Digestion; 2012; 86(4):329-37. PubMed ID: 23207161 [TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Grabenbauer GG; Lahmer G; Distel L; Niedobitek G Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of T lymphocytes infiltration in breast cancer]. Yu HM; Jiao SC; Yang JL; Wang JD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010 [TBL] [Abstract][Full Text] [Related]
19. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835 [TBL] [Abstract][Full Text] [Related]
20. In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis. Abe H; Morikawa T; Saito R; Yamashita H; Seto Y; Fukayama M Virchows Arch; 2016 May; 468(5):539-48. PubMed ID: 26915031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]